🛒 How to order this item?
100% Genunie Product
Safe & Secure Payment
Secure & Effecient Delivery
Proper Packaging
Show More
Emistat FT is a medication used to control and prevent nausea and vomiting caused by medical conditions such as stomach upset, surgery, cancer drug therapy, or radiotherapy. It can be taken alone or in combination with other medications, with or without food. The appropriate dose is determined by a doctor and is typically taken regularly at the same time each day. While Emistat 8 may cause side effects such as headaches, diarrhea, and tiredness, these symptoms should go away when the medication is stopped. It is important to inform your doctor of any heart or liver problems, stomach or intestinal blockages, and other medications you may be taking before starting treatment with Emistat 8. Pregnant or breastfeeding individuals should consult their doctor before taking this medication.
There are no harmful side effects associated with consuming alcohol while taking Emistat FT 8.
While limited human studies have been conducted, Emistat FT 8 is generally considered safe to use during pregnancy as animal studies have shown low or no adverse effects on the developing baby.
Limited human data suggests that Emistat FT 8 is probably safe to use during breastfeeding, as it does not pose a significant risk to the baby.
Emistat FT 8 does not affect your ability to drive.
Emistat FT 8 is safe to use in patients with kidney disease. If you face any problems please consult your doctor.
Due to a lack of research, there are limited information available on the use of Emistat FTt 8 in patients with liver disease. Please consult your doctor.
Emistat 8mg Tablet side effects may include dizziness, drowsiness, diarrhea, constipation, and headache. These side effects are usually minor and disappear within a few days or 1-2 weeks. If these symptoms persist for an extended period, you should see a doctor. Emistat FT 8mg Tablet may cause some serious side effects that necessitate immediate medical attention.
Please follow your doctor's instructions regarding the dose and duration of Emistat FT 8. It is important to avoid handling the tablets with wet hands. Place the tablet in your mouth but do not swallow it. You may take Emistat FT 8 with or without food, but it's recommended to take it at the same time each day.
Emistat FT 8mg Tablets are used to relieve nausea and vomiting brought on by procedures like surgery, chemotherapy, and radiation therapy. This is a type of medication called an antiemetic. This medication works by preventing the release of the chemical serotonin in your intestines and central nervous system. This will stop nausea and vomiting.
"Emistat FT 8mg" There are four oral tablet dosage options: tablet, disintegrating (dissolving) tablet, solution, and film. A doctor can alternatively inject it into your body using the intravenous (IV) form that is also available. It can be taken either with or without food.
Emistat FT 8 may be a potent and intensely focused 5HT3 receptor antagonist. Its precise mechanism of operation under the influence of illness and heaving is unknown. By acting on vagal afferents via 5HT3 receptors, chemotherapeutic agents and radiotherapy may trigger the release of 5HT within the small intestine, initiating a spewing reflex. Ondansetron prevents this response from activating. The activation of vagal afferents may also release 5HT into the zone postrema, which is located on the floor of the fourth ventricle, which may further exacerbate emesis through a central mechanism. In this sense, the effect of ondansetron in the treatment of illness and the vomiting induced by cytotoxic chemotherapy and radiotherapy is probably caused by the antagonistic nature of 5HT3 receptors on neurons present in both the peripheral and central nervous systems. Although the mechanisms causing post-operative nausea and heaving are unknown, there may be shared pathways with cytotoxically induced illness and heaving.
Cancer Treatment-Related Nausea and Vomiting
Adults, children (6 months to 18 years old):
Eight-milligram pill orodispersible: Three 0.15 mg/kg measures, with a maximum dose of 16 milligrams.
Three 0.15 mg/kg readings, up to a maximum of 16 mg per dose, on a 4 mg orodispersible tablet.
injection: three doses of 0.15 mg/kg, administered intravenously over a 15-minute period with a maximum dose of 16 mg.
Vomiting and Illness from Radiotherapy
Adults:
8 mg tablet/orodispersible tablet: Begin with Measurements: 8 mg orally 1 to 2 hours after radiotherapy. Post-radiotherapy: 8 mg orally every 8 hours for up to 5 days after treatment.
4 mg orodispersible tablet: three 0.15 mg/kg measurements, with a maximum dose of 16 mg.
Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, administered intravenously over 15 minutes.
Postoperative Nausea and Vomiting-
Adults:
16 mg given as two 8 mg tablets (8 mg tablet/orodispersible tablet)
16 mg orodispersible tablet
4 mg injection
Pediatrics (>40 kg): 4 mg infusion
Pediatrics (40 kg): 0.1 mg/kg infusion
Tramadol's analgesic effect may be reduced. Rifampicin and other CYP3A4 inducers may reduce ondansetron levels/effects. Concurrent use of QT-prolonging agents (e.g., antiarrhythmics) may result in additive QT interval prolongation. Cardiotoxic drugs may increase the risk of arrhythmias (e.g. anthracyclines). Potentially lethal: May increase apomorphine's hypotensive effect.
Contraindicated in patients known to have extreme touchiness to the medication or any of its components. Concomitant utilization of apomorphine.
Pregnancy Category B. Ondansetron is excreted within the breast milk of rats. It isn't known whether ondansetron is excreted in a human drain. Since numerous drugs are excreted in the human brain, caution ought to be worked out when ondansetron is managed by a nursing lady.
Touchiness responses, counting anaphylaxis and bronchospasm, have been detailed with or without known touchiness to other particular 5-HT3 receptor enemies. QT prolongation happens in a dose-dependent way.
Store at a temperature not surpassing 30ºC in a dry put. Secure from light and dampness.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.